NewsGlobeNewswire
Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients
· Published
Article summary
"By undertaking these important bioanalytical activities, we are going to obtain great insight into the effects of PPC-001”
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…